Table 3.
Variables | Model 1 | Model 2 |
---|---|---|
Year of death (each increasing year) | 1.052 (1.044–1.060) | 1.066 (1.058–1.075) |
Age at death (each increasing year) | 0.970 (0.966–0.973) | |
Gender | ||
Male | 1.0 | |
Female | 0.965 (0.918–1.015) | |
Race | ||
Non-Hispanic white | 1.0 | |
Black | 1.070 (0.985–1.162) | |
Hispanic | 1.380 (1.216–1.565) | |
Others | 1.291 (1.154–1.444) | |
Low socioeconomic status | ||
No | 1.0 | |
Yes | 1.094 (1.025–1.167) | |
Teaching hospital | ||
No | 1.0 | |
Yes | 1.078 (1.021–1.167) | |
Cause of death | ||
Other than lung cancer | 1.0 | |
Lung cancer | 0.697 (0.655–0.742) | |
Comorbidity score | ||
0 | 1.0 | |
1 | 1.200 (1.124–1.281) | |
≥ 2 | 1.622 (1.525–1.7425) | |
Married | ||
No | 1.0 | |
Yes | 1.119 (1.063–1.179) | |
Place of residence | ||
Nonlarge metropolitan area | 1.0 | |
Large metropolitan area | 1.556 (1.479–1.636) | |
AJCC stage | ||
IIIB | 1.0 | |
IV | 0.685 (0.652–0.720) | |
Chemotherapy use | ||
No | 1.0 | |
Yes | 0.915 (0.869–0.964) |
Values are presented as odds ratio (95% confidence interval). Model 1 = unadjusted odds of ICU use in the last 6 months of life by death year; model 2 = model 1 + age at death, gender, low socioeconomic status, cause of death, comorbidity score, marital status, AJCC stage, race, place of residence, chemotherapy use, and major medical school affiliation. See Table 1 for abbreviation not used in the text.